Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany
Lordick, Florian, Ehlken, Birgit, Ihbe-Heffinger, Angela, Berger, Karin, Krobot, Karl J, Pellissier, James, Davies, Glenn, Deuson, Robert
Published in European journal of cancer (1990) (01.01.2007)
Published in European journal of cancer (1990) (01.01.2007)
Get full text
Journal Article
Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
Egerer, Gerlinde, Reichert, Dietmar, Pletz, Mathias W, Kaskel, Peter, Krobot, Karl J, Maertens, Johan
Published in European journal of medical research (17.04.2012)
Published in European journal of medical research (17.04.2012)
Get full text
Journal Article
Lifetime cost of ischemic stroke in germany : Results and national projections from a population-based stroke registry the erlangen stroke project
KOLOMINSKY-RABAS, Peter L, HEUSCHMANN, Peter U, MARSCHALL, Daniela, EMMERT, Martin, BALTZER, Nikoline, NEUNDÖRFER, Bernhard, SCHÖFFSKI, Oliver, KROBOT, Karl J
Published in Stroke (1970) (01.05.2006)
Published in Stroke (1970) (01.05.2006)
Get full text
Journal Article
Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins
Krobot, Karl J, Wagner, Alexander, Siebert, Uwe
Published in European journal of preventive cardiology (01.02.2012)
Published in European journal of preventive cardiology (01.02.2012)
Get more information
Journal Article
Prospective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries
Ullmann, Andrew J., Sanz, Miguel A., Tramarin, Andrea, Barnes, Rosemary A., Wu, Wenchen, Gerlach, Barbara A., Krobot, Karl J., Gerth, William C.
Published in Clinical infectious diseases (15.08.2006)
Published in Clinical infectious diseases (15.08.2006)
Get full text
Journal Article
Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value
Krobot, Karl J, Ferrante, Shannon Allen, Davies, Michael J, Seck, Thomas, Meininger, Gary E, Williams-Herman, Debora, Kaufman, Keith D, Goldstein, Barry J
Published in Current medical research and opinion (01.08.2012)
Published in Current medical research and opinion (01.08.2012)
Get more information
Journal Article
Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany
Michailov, Galin V., Davies, Glenn M., Krobot, Karl J.
Published in The European journal of health economics (01.06.2012)
Published in The European journal of health economics (01.06.2012)
Get full text
Journal Article
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study
Wissing, Heimo, Ballus, Jose, Bingold, Tobias M, Nocea, Gonzalo, Krobot, Karl J, Kaskel, Peter, Kumar, Ritesh N, Mavros, Panagiotis
Published in Infection and drug resistance (2013)
Published in Infection and drug resistance (2013)
Get full text
Journal Article
Blood pressure control in the year following coronary events
Müller-Nordhorn, Jacqueline, Völler, Heinz, Pfennig, Andrea, Binting, Sylvia, Krobot, Karl J, Willich, Stefan N
Published in International journal of cardiology (12.11.2008)
Published in International journal of cardiology (12.11.2008)
Get full text
Journal Article
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway
Cook, John R, Yin, Don, Alemao, Evo, Davies, Glenn, Krobot, Karl J, Veltri, Enrico, Lipka, Leslie, Badia, Xavier
Published in PharmacoEconomics (01.01.2004)
Published in PharmacoEconomics (01.01.2004)
Get full text
Journal Article
Quantifying delay in access to new medical treatment: an application of risk advancement period methodology
Krobot, Karl J, Miller, William C, Kaufman, Jay S, Christensen, Dale B, Preisser, John S, Ibrahim, Michel A
Published in Epidemiology (Cambridge, Mass.) (01.03.2004)
Published in Epidemiology (Cambridge, Mass.) (01.03.2004)
Get more information
Journal Article
Berufliche Wiedereingliederung nach kardiologischer Rehabilitation
Willich, Stefan N., M ller-Nordhorn, Jacqueline, Gehring, J rgen, Kulig, Michael, Klein, Gernot, Gohlke, Helmut, V ller, Heinz, Bestehhorn, Kurt, Krobot, Karl J., Binting, Sylvia
Published in International journal of public health (01.12.2003)
Published in International journal of public health (01.12.2003)
Get full text
Journal Article
Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors
Krobot, Karl J, Yin, Donald D, Alemao, Evo, Steinhagen-Thiessen, Elisabeth
Published in European journal of cardiovascular prevention and rehabilitation (01.02.2005)
Published in European journal of cardiovascular prevention and rehabilitation (01.02.2005)
Get more information
Journal Article
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: Application to Germany, Spain and Norway: Realities of lipid management and cost effectiveness of dual inhibition therapy
COOK, John R, DON YIN, ALEMAO, Evo, DAVIES, Glenn, KROBOT, Karl J, VELTRI, Enrico, LIPKA, Leslie, BADIA, Xavier
Published in PharmacoEconomics (2004)
Get full text
Published in PharmacoEconomics (2004)
Journal Article